Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro
Watch On Demand
In this webinar hosted by DDW and supported by bit.bio, Dr Stephen Ferguson, Investigator, Mechanistic Toxicology, Division of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, explores the complexities of in vitro modelling for human liver toxicity and pharmacology. He discusses the development and implementation of advanced cell systems mimicking liver functionality and their responses to various chemical exposures, including PFAS and botanical mixtures. Dr Ferguson sheds light on the principles guiding effective models, the common pitfalls encountered in research, and the promising advancements being made in this vital field of environmental health.
Tom Brown, Senior Product Manager at bit.bio, presents a new liver research toolkit featuring human iPSC-derived hepatocytes deterministically programmed with opti-ox technology, offering solutions for advancing disease modelling and drug discovery and representing a potential alternative to primary human hepatocytes and immortalised cell lines.
The presentations are followed by a Q&A session.
